TABLE 3.
Univariate Cox proportional hazards model predicting PCSM for men with metastasis after RP
| HR | 95% CI | p Value | No. With Data | |
|---|---|---|---|---|
| Time from RP to metastasis | 0.99 | 0.98–0.998 | 0.024 | 91 |
| Time to PSA failure | 0.99 | 0.97–1.00 | 0.100 | 91 |
| Log (preop PSA) | 1.07 | 0.75–1.53 | 0.704 | 89 |
| Age | 1.03 | 0.95–1.06 | 0.897 | 91 |
| Preop Gleason grade 4 + 3 or greater | 1.44 | 0.67–3.09 | 0.340 | 87 |
| Pathological Gleason grade 4 + 3 or greater | 1.92 | 0.92–3.99 | 0.083 | 91 |
| Organ confined disease | 0.73 | 0.22–2.36 | 0.594 | 91 |
| Pos surgical margins | 1.36 | 0.73–2.52 | 0.334 | 91 |
| PSADT at PSA failure less than 3 mos | 1.45 | 0.57–3.57 | 0.441 | 60 |
| PSADT before metastasis less than 3 mos | 3.01 | 1.26–7.19 | 0.016 | 59 |
| ECOG performance status greater than 1 | 1.36 | 0.41–4.50 | 0.621 | 75 |
| Presence of pain | 2.97 | 1.45–6.06 | 0.002 | 74 |
| Presence of appendicular metastases | 1.42 | 0.65–3.12 | 0.378 | 76 |
| Comorbid CAD | 1.21 | 0.42–3.50 | 0.716 | 80 |
| Absolute PSA at metastasis 100 ng/ml or greater | 1.54 | 0.67–3.48 | 0.294 | 76 |